Analyst Ratings for C4 Therapeutics (CCCC)
CCCC Rating Summary
CCCC Price Target Summary
- Highest: $30.00 (Brookline Capital Markets)
- Lowest: $6.00 (Stephens)
- Average: $12.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.20 (+301.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$12.20 (+301.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2025 | TD Cowen » Updated 2/26/2026 |
Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
2.54 (3.04) |
19.69% | Details |
| 9/15/2025 | Stephens | Sudan Loganathan | Upgrade | Overweight (Equal Weight) |
6.00 (N/A) |
2.66 (3.04) |
14.29% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
